{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:01:54Z","timestamp":1790197314116,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:23:17Z","timestamp":1785928997000},"page":"789-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-1843","authenticated-orcid":false,"given":"Ashley","family":"Monaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka S.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Palasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Lawen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Donalisio","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2026.07.007_bib0001","first-page":"123","article-title":"Active surveillance for low-risk prostate cancer \u2013 in pursuit of a standardized protocol","volume":"73","author":"Sosnowski","year":"2020","journal-title":"Cent Eur J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.007_bib0002","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/JU.0000000000000713","article-title":"Long-term outcomes of active surveillance for prostate cancer: the Memorial Sloan Kettering Cancer Center experience","volume":"203","author":"Carlsson","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.007_bib0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrurol.2016.45","article-title":"Active surveillance for prostate cancer: current evidence and contemporary state of practice","volume":"13","author":"Tosoian","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.007_bib0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.urology.2006.09.054","article-title":"Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale","volume":"69","author":"Batista-Miranda","year":"2007","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.007_bib0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I\u2014Initial work-up and medical Management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.007_bib0006","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JU.0000000000002184","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II\u2014Surgical evaluation and treatment","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.007_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline Amendment 2023","volume":"211","author":"Sandhu","year":"2024","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.007_bib0008","first-page":"4699","article-title":"What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review","volume":"30","author":"Donachie","year":"2022","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2026.07.007_bib0009","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.12968\/bjon.2021.30.10.S30","article-title":"The psychological impact of active surveillance in men with prostate cancer: implications for nursing care","volume":"30","author":"Biddle","year":"2021","journal-title":"Br J Nurs"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.007_bib0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.6004\/jnccn.2016.0022","article-title":"Impact of prostate cancer diagnosis on noncancer hospitalizations among elderly medicare beneficiaries with incident prostate cancer","volume":"14","author":"Raval","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 6","key":"10.1016\/j.urolonc.2026.07.007_bib0011","article-title":"MP28-12 Lower urinary tract symptoms and utilization of bladder outlet procedures in patients with prostate cancer on active surveillance","volume":"205","author":"Jiang","year":"2021","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.07.007_bib0012","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1464-410X.2010.09356.x","article-title":"The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer","volume":"106","author":"Krupski","year":"2010","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.007_bib0013","first-page":"167","article-title":"Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates","volume":"83","author":"Schober","year":"2023","journal-title":"Prostate"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2026.07.007_bib0014","article-title":"PD10-05 Clinical and pathologic outcomes following holmium laser enucleation of the prostate in men undergoing active surveillance","volume":"201","author":"Nottingham","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.007_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.urology.2021.01.040","article-title":"Photoselective vaporization of the prostate in the management of lower urinary tract symptoms in prostate cancer patients on active surveillance","volume":"156","author":"Jibara","year":"2021","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.007_bib0016","doi-asserted-by":"crossref","first-page":"297.e1","DOI":"10.1016\/j.urolonc.2020.11.003","article-title":"Management of prostate cancer after holmium laser enucleation of the prostate","volume":"39","author":"Hutchison","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.007_bib0017","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.eururo.2007.07.027","article-title":"Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement","volume":"53","author":"Suardi","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.007_bib0018","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2009.06.078","article-title":"External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity","volume":"77","author":"Devisetty","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.007_bib0019","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.euf.2020.09.003","article-title":"Initial experience with radical prostatectomy following holmium laser enucleation of the prostate","volume":"7","author":"Kretschmer","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"8","key":"10.1016\/j.urolonc.2026.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/end.2021.0875","article-title":"Robot-assisted radical prostatectomy after prior transurethral resection of the prostate: an analysis of perioperative, functional, pathologic, and oncologic outcomes","volume":"36","author":"Bajpai","year":"2022","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.007_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bju.13193","article-title":"Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance","volume":"118","author":"Davis","year":"2016","journal-title":"BJU Int"},{"issue":"Suppl 9","key":"10.1016\/j.urolonc.2026.07.007_bib0022","first-page":"S3","article-title":"Benign prostatic hyperplasia: an overview","volume":"7","author":"Roehrborn","year":"2005","journal-title":"Rev Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.007_bib0023","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-5347(01)64508-7","article-title":"Natural history of prostatism: risk factors for acute urinary retention","volume":"158","author":"Jacobsen","year":"1997","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.007_bib0024","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41391-024-00837-9","article-title":"Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?","volume":"28","author":"Bologna","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392600606X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392600606X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:08:32Z","timestamp":1790194112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392600606X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S107814392600606X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}